Hamilton Square Partners Management provides investment advisory services to private funds, investment advisors, and institutional managed accounts. They focus on pre-initial public offering investments and private investments in public equity within the biotech sector. They also intend to incorporate a market neutral strategy that invests in large-cap publicly traded biopharma global companies. Hamilton Square manages investments based on guidelines set forth in the governing documents of the funds and does not tailor its services to individual investors.
Fee Structure
Hamilton Square manages investments for private funds and institutional managed accounts.
For the Biotech Private Funds, the annual management fee is 2.0%, paid quarterly in advance.
For the Synapse Funds, the annual management fee ranges from 1.25% to 2.0%, depending on the class of interest, paid quarterly in advance.
For institutional managed accounts, the fee is either an annual management fee based on assets under management or an expense reimbursement, as detailed in the Investment Management Agreement.